Lymphoscintigraphy is a highly specialized and minimally invasive nuclear medicine scan used to evaluate the lymphatic system. It is widely recognized as the gold standard imaging technique for diagnosing peripheral lymphedema, assessing lymphatic drainage, and identifying abnormalities in lymphatic transport pathways. This test provides crucial insights into lymphatic dysfunction, including congenital and acquired causes, and helps guide both medical and surgical treatment plans. In clinical practice, lymphoscintigraphy is a well-established, safe, and functional test that allows real-time assessment of lymph flow, lymphatic obstruction, and dermal backflow. It plays a key role in differentiating between primary lymphedema (present since birth or adolescence) and secondary lymphedema (usually caused by cancer, surgery, or radiation).
What is Lymphoscintigraphy?
Lymphoscintigraphy is a nuclear medicine imaging procedure that evaluates the functionality of the lymphatic vessels and lymph nodes. It uses a small amount of a radioactive tracer—typically 99mTc-labeled colloid—which is injected just beneath the skin (subcutaneously) in the hands or feet, depending on the body part being studied. Once injected, the tracer is absorbed by the lymphatic vessels and follows the natural lymph flow towards the regional lymph nodes. A gamma camera then captures dynamic images that reveal the speed, direction, and completeness of lymphatic drainage.
Why is Lymphoscintigraphy Performed?
Lymphoscintigraphy is recommended when there is persistent swelling (edema) of the arms, legs, or other body parts that may be due to lymphatic dysfunction. This scan helps clinicians confirm or rule out lymphedema and aids in treatment planning and disease monitoring.
Common Indications for Lymphoscintigraphy:
Diagnosis of primary or secondary lymphedema
Unexplained limb swelling (usually chronic or recurrent)
Post-surgical lymphedema, especially after lymph node removal in cancer treatment
Radiation-induced lymphatic damage
Pre-operative assessment for lymphatic bypass surgery or lymph node transfer
Monitoring lymphatic function in chronic cases
Evaluation of congenital lymphatic abnormalities
Differentiating venous insufficiency from lymphatic obstruction
Types of Lymphedema Evaluated
Lymphoscintigraphy is instrumental in identifying the type and severity of lymphedema.
Primary Lymphedema
Due to congenital or hereditary defects in lymphatic development
Includes Milroy disease, Meige disease, and late-onset primary lymphedema
Secondary Lymphedema
More common and often results from surgery, radiation, infection, or cancer
Seen frequently after breast cancer treatment, pelvic surgeries, or lymphoma
This test helps visualize whether the lymphatic vessels are present, absent, underdeveloped, or blocked, and to what extent.
How is Lymphoscintigraphy Performed?
The procedure is simple, safe, and typically performed in an outpatient setting. It involves only mild discomfort at the injection site and no major preparation is required.
Step-by-Step Procedure:
Patient Preparation
No fasting or sedation is required
The patient is informed about the procedure and consent is obtained
Jewelry or accessories are removed from the affected area
Tracer Injection
A small dose of 99mTc-sulfur colloid or 99mTc-nanocolloid is injected subcutaneously
Common injection sites include the web spaces of hands or feet, depending on the limb involved
Imaging Process
A gamma camera is used to obtain dynamic and static images
Initial imaging begins immediately to observe tracer movement through lymphatic vessels
Follow-up imaging at intervals (30 minutes to 2 hours) may be done to track delayed flow
Post-Imaging Protocol
In some cases, mild exercise (e.g., walking or movement of the limb) may be recommended to facilitate lymph flow
The total procedure duration may vary from 1 to 3 hours, depending on clinical needs
What Does Lymphoscintigraphy Show?
This test provides functional imaging of the lymphatic system, allowing doctors to assess:
Presence or absence of lymphatic flow
Speed of lymph movement
Symmetry between limbs
Presence of dermal backflow or collateral circulation
The information from lymphoscintigraphy is crucial for diagnosis, staging, and management of lymphatic disorders. It helps determine the severity of lymphedema, the need for surgical intervention, or whether conservative management like compression therapy is sufficient.
Benefits Include:
Gold standard for confirming lymphedema
Differentiates lymphatic edema from other causes of swelling
Offers detailed assessment for pre-surgical mapping
Allows monitoring of disease progression and response to therapy
Non-invasive, safe, and does not require iodinated contrast
Effective in pediatric and adult patients
Limitations of the Test
While highly reliable, lymphoscintigraphy has some limitations:
Cannot provide anatomical details like MRI or CT
May not detect very small lymphatic channels
Limited availability in some centers
Interpretation requires experienced nuclear medicine specialists
Results may vary based on technique, tracer, and timing of images
Preparation and Safety
This scan is generally well-tolerated with no significant side effects or complications.
The radiation dose is very low and safe for all age groups
No contrast medium is required
Patients can resume normal activities immediately after the test
Pregnant or breastfeeding women should inform the physician in advance
Conclusion
Lymphoscintigraphy is a powerful and accurate nuclear medicine imaging test that plays a vital role in the diagnosis and management of lymphedema. Recognized as the gold standard in evaluating lymphatic disorders, it offers unparalleled functional insights into the drainage capacity, obstruction, and flow pattern of the lymphatic system. From diagnosing primary and secondary lymphedema to planning surgical interventions and monitoring therapeutic responses, lymphoscintigraphy remains an essential tool in modern clinical practice. Its minimally invasive nature, high diagnostic accuracy, and safe application across age groups make it the preferred choice for assessing lymphatic dysfunction and guiding patient-specific management strategies.
Test information: Fasting NOT needed
Reporting: Within 2 hours*
No Fasting is needed.
Please carry all medical documents, including doctor referrals, previous reports, etc.
Female patients are to inform their status of pregnancy and lactation.
उपवास की आवश्यकता नहीं है।
कृपया डॉक्टर रेफरल, पिछली रिपोर्ट आदि यदि कोई हो, सहित सभी चिकित्सा दस्तावेज साथ रखें।
महिला रोगियों को अपनी गर्भावस्था और स्तनपान की स्थिति के बारे में सूचित करना होता है।
After registration and payment, the patient's medical history is taken, including checking referral, medical & surgical treatment details, investigation records, etc. Informed consent is also obtained at the same time.
The patient is given intradermal injections into their feet and hands in interphalangeal space.
Whole body and static images are acquired at 30 minutes, 2 hours, 4 hours, and if required, at 24 hours to see the flow of the lymphatic channel.
* For details, please see service-related policies